Background: Domestic cat hepadnaviruses (DCHs) have been described as a novel virus that can infect cats.Objective: The aim of our study is the first identification and molecular characterizations of DCH infection in Turkish domestic cats.Methods: The blood, organ and ascites fluid samples from 550 cats were randomly sampled. The presence of DCH nucleic acid was investigated by using both in the literature and newly designed primers.Results: It was found that the hepadnavirus positivity rate is 4% (22/550) in Türkiye. The full genomic characterization was performed on 13 of 22 samples, and others were characterized as nearly full genome. In this study, we highlight that whole blood samples should be also screened for DCH, not only serum samples as has frequently been done in other studies. DCH‐infected cats were also found positive (54.54%, 12/22) forFeline leukaemia virusinfection. BLAST results revealed that Turkish DCHs have 86.32%–99.08% homology with strains in the GenBank database, enabling us to construct phylogenetic trees.Conclusions: According to this study's results, it is suggested that this infection should be added to veterinary diagnostic panels worldwide. Additionally, we suggest that our new synthesized primers for the amplification of X gene can also be used for diagnosis.
Feline leukaemia virus (FeLV) is a member of the Gammaretrovirus genus, which has two genotypes in cats: endogenous (replication-defective provirus) and exogenous (replication-competent). In this study, 550 cats were examined, and 112 of them (20.36%) were found to have the endogenous FeLV (enFeLV) genotype. EnFeLV-positive animals were also tested for additional viral infections, and 48 cats (42.85%) were discovered to be co-infected with other viruses. According to co-infection data, these cats were infected with feline coronavirus (FCoV) (27/112, 24.1%), feline panleukopenia virus (FPV) (14/112, 12.5%), feline immunodeficiency virus (FIV) (0/112, 0%), and domestic cat hepadnavirus (DCH) (13/112, 11.6%). Their age, sex, breed, clinical state, lifestyle (in/outdoor), and immunization data against FeLV were also evaluated. In line with our results, the prevalence of enFeLV and co-infection with other pathogens in cats admitted to the clinic for various reasons were discussed. The majority of positive animals in terms of FeLV (94/112, 83.93%) had clinical findings. We emphasized that the FeLV-positive situation of cats should be taken into consideration by veterinarians when planning treatment and vaccination programs. Additionally, in this study, we questioned the group in which our enFeLVs were phylogenetically located. Therefore, we performed a phylogenetic analysis based on a comparison with global FeLV sequences obtained from the GenBank database. The sequenced positive samples were in the AGTT subgroup within Group-II.
Endometriosis is characterized by enhanced cellular proliferation, migration, and resistance to apoptosis, contributing to lesion persistence and progression. Targeting cellular plasticity and mesenchymal-associated functions may therefore represent a promising therapeutic strategy. Here, we investigated the effects of Pelargonium graveolens essential oil (PGEO) on proliferation, apoptosis, migration, cytoskeletal organization, transcriptional regulation, and metabolic alterations in human endometriotic 12Z cells. PGEO treatment suppressed proliferative capacity in a concentration-dependent manner and significantly impaired cell migration, accompanied by reduced β-tubulin expression and decreased levels of mesenchymal-associated markers CD73 and CD105. Increased GRP78 expression together with ultrastructural alterations, including cytoplasmic vacuolization and mitochondrial and endoplasmic reticulum changes, indicated activation of cellular stress responses. Although transcriptional analysis revealed increased CCND1 and PIK3CA mRNA levels, these changes did not parallel the observed suppression of proliferation, suggesting compensatory regulatory responses. Untargeted metabolomic profiling revealed alterations in energy metabolism characterized by increased levels of glycolysis-related metabolites, reduced levels of several amino acids including glutamine and histidine, and changes in lipid-associated metabolites. Collectively, these findings demonstrate that PGEO suppresses proliferative and migratory behavior in endometriotic cells while modulating cytoskeletal, transcriptional, and metabolic pathways, highlighting its potential as a candidate for further investigation in endometriosis-targeted therapeutic strategies.
The envelope (env) protein of SARS-CoV-2, a pivotal component of the viral architecture, plays a multifaceted role in viral assembly, replication, pathogenesis, and ion channel activity. These features make it a significant target for understanding virus–host interactions and developing vaccines to combat COVID-19. Recent structural studies provide valuable insights into the conformational dynamics and membrane topology of the SARS-CoV-2 env protein, shedding light on its functional mechanisms. The strong homology and highly conserved structure of the SARS-CoV-2 env protein shape its immunogenicity and functional characteristics. This study examines the ability of the recombinant SARS-CoV-2 env protein to stimulate an immune response. In this study, recombinant envelope proteins were produced using the baculovirus expression system, and their potential efficacy was evaluated in both in vivo and in vitro models. Our results reveal that the env protein of SARS-CoV-2 stimulates humoral and cellular responses and highlight its potential as a promising vaccine candidate for combating the ongoing pandemic.
Equine herpesvirus type 1 (EHV-1) is a major viral pathogen of horses, causing respiratory disease, abortion, and neurological disorders, while current vaccines provide only limited protection. This study aimed to evaluate the in vitro cytoprotective potential of recombinant human interferon-gamma (rhIFN-γ) and its capacity for the reduction of cytopathic damage in equine dermal cells. The human IFN-γ gene was cloned into a bacterial expression vector, expressed in Escherichia coli, and purified using affinity chromatography. Equine dermal (ED) cells were treated with different concentrations of rhIFN-γ prior to viral challenge. Cytotoxicity was assessed using the MTT assay, and cytoprotective activity was evaluated through cytopathic effect (CPE) observations and TCID50 titration. The results demonstrated that rhIFN-γ reduced EHV-1-induced cytopathic effects in a dose-dependent manner, with the most pronounced protective activity observed at 200 and 400 ng/mL. Additionally, treated cells showed significantly higher viability compared to infected controls (p < 0.05). These findings indicate that bacterially produced rhIFN-γ exhibits both antiviral and cytoprotective effects against EHV-1 in vitro and may represent a promising candidate for the development of alternative potential antiviral strategies targeting EHV-1 infections in horses. These findings indicate that bacterially produced rhIFN-γ exhibits notable cytoprotective activity in vitro by mitigating cellular injury following EHV-1 exposure.
About Me
Eda Erdem-Şahinkesen, PhD student, Ankara University
Eda Erdem-Şahinkesen, PhD student, Ankara University